<table id="table8" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8:	Pharmacokinetic Parameters of Total Doxorubicin from DOXIL in Patients With AIDS-Related Kaposi's Sarcoma</caption>
<col align="left" valign="top" width="50%"></col>
<col align="center" valign="top" width="25%"></col>
<col align="center" valign="top" width="25%"></col>
<thead>
<tr>
<th></th>
<th colspan="2" stylecode="Botrule">Dose</th>
</tr>
<tr>
<th>Parameter (units)</th>
<th>10 mg/m<sup>2</sup>
</th>
<th>20 mg/m<sup>2</sup>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="3">N=23<br/>Mean ± Standard Error</td>
</tr>
</tfoot>
<tbody>
<tr>
<td>Peak Plasma Concentration (µg/mL)</td>
<td>4.12 ± 0.215</td>
<td>8.34 ± 0.49</td>
</tr>
<tr>
<td>Plasma Clearance (L/h/m<sup>2</sup>)</td>
<td>0.056 ± 0.01</td>
<td>0.041 ± 0.004</td>
</tr>
<tr>
<td>Steady State Volume of Distribution (L/m<sup>2</sup>)</td>
<td>2.83 ± 0.145</td>
<td>2.72 ± 0.120</td>
</tr>
<tr>
<td>AUC (µg/mL∙h)</td>
<td>277 ± 32.9</td>
<td>590 ± 58.7</td>
</tr>
<tr>
<td>First Phase (λ<sub>1</sub>) Half-Life (h)</td>
<td>4.7 ± 1.1</td>
<td>5.2 ± 1.4</td>
</tr>
<tr>
<td>Second Phase (λ<sub>1</sub>) Half-Life (h)</td>
<td>52.3 ± 5.6</td>
<td>55.0 ± 4.8</td>
</tr>
</tbody>
</table>